Liling Zhang

Academic / Other · 2 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	Hypofractionation Radiotherapy in Combination with Glofitamab in Relapsed/refractory Diffuse B-cell Lymphoma w Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Lymphoma	Phase 2	2025-04-01
Unknown	Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Di Newly Diagnosed Peripheral T-cell Lymphoma	Phase 2	2023-05-08